20th BioPharma Drug Discovery Nexus Conference

20th BioPharma Drug Discovery Nexus Conference

20th BioPharma Drug Discovery Nexus Conference

20th BioPharma Drug Discovery Nexus Conference

Join Model Medicines in San Diego, California, on May 8-9 for the 20th BioPharma Drug Discovery Nexus Conference.
Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships and Investor Relations

Daniel Haders, the CEO of Model Medicines, will be participating as a panelist, bringing his expertise to the conference. The event covers a wide range of drug discovery topics and offers excellent networking opportunities. Daniel will delve into the theme "Advancing Hit Discovery for Complex and Emerging Targets," aligning seamlessly with Model Medicines' groundbreaking work.

For more information about Model Medicines post-conference, visit www.modelmedicines.com/investors or get in touch with us directly.